← FDA Drug Approvals (Drugs@FDA)
IVERMECTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2026-02-26
Drug application
- FDA Application #
ANDA216863
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IVERMECTIN
- Generic name
- IVERMECTIN
- Active ingredients
- IVERMECTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ZYDUS LIFESCIENCES
- Manufacturer
- Zydus Lifesciences Limited
- First approval
- 2026-02-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown